ArticleIndian journal of clinical biochemistry : IJCB2025
The Effects of Alpha Linolenic Acid (Omega-3 Fatty Acid) on Tobacco Craving Intensity, Withdrawal Symptoms and Biochemical Markers in Tobacco Users.
Article in Indian journal of clinical biochemistry : IJCB, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synergistic Beneficial Effects of Flaxseed (Food science & nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tobacco use causes serious public health concerns and causes many health problems like (asthma, COPD, stroke, cancer, etc.). While a number of pharmacological treatments are used to reduce tobacco use, they often have adverse effects. Fewer studies have assessed non-pharmacological treatments {Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA) or fish oil} to reduce tobacco use. Omega-3 fatty acids, already known for their benefits in reducing bad cholesterol, managing diabetes, and helping with fatty liver, are now being studied for their potential impact on smoking habits. We aimed to evaluate the effect of omega-3 supplementation (flaxseed oil as a vegetarian source of alpha-linolenic acid, ALA) on tobacco craving intensity, withdrawal symptoms, and various biochemical markers in tobacco users. This single-blind, placebo-controlled study involved 104 tobacco users divided into two groups: omega-3 (n = 54) receiving 10 ml flaxseed oil daily for 6 months and placebo (n = 50). We measured tobacco craving intensity {Visual Analogue Scale (VAS)}, withdrawal symptoms {Minnesota Nicotine Withdrawal Scale (MNWS)}, demographic parameters (BMI, WHR, BP, HR), and biochemical parameters (LFT, KFT, Lipid Profile) at baseline and after 6 months. Six-month consumption of edible grade pure flaxseed oil resulted in significant lowering of BMI in omega-3 group when compared to placebo group (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.